ClinicalTrials.Veeva

Menu

The Effectiveness of High-flow Nasal Cannula After Extubation in Patients

Chang Gung Medical Foundation logo

Chang Gung Medical Foundation

Status

Completed

Conditions

Post Extubation Respiratory Failure

Study type

Observational

Funder types

Other

Identifiers

NCT06746363
202200799B0

Details and patient eligibility

About

Observe the current status of prolonged mechanical ventilation (PMV) patients using high-flow nasal cannula oxygen therapy (experimental group) or traditional oxygen therapy (control group) after extubation, and compare the differences in ventilator weaning rates between the two groups.

Record the ROX index (SpO2/FiO2/RR) at 2, 6, 12, and 24 hours after extubation in PMV patients and explore whether statistical methods can predict the weaning outcome within seven days.

Use statistical methods to analyze whether comorbidities in the PMV population affect ventilator weaning rates.

Enrollment

110 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients over 20 years old and expected to undergo extubation.

Exclusion criteria

  • Patients with tracheostomy who will use non-invasive or invasive ventilators immediately after extubation.

Trial design

110 participants in 2 patient groups

HFNC group
Description:
HFNC support post extubation
oxygen therapy
Description:
oxygen therapy post extubation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems